Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC

Clinical trial NCT06494943 · RECRUITING

Trial details

NCT number: NCT06494943
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2024-06-26
Primary completion: 2026-12-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.